Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
A straightforward, step-by-step budgeting tool introduction that helps you plan expenses, adjust forecasts, and save more.
16,463 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
A Delaware bankruptcy judge cleared Terraform’s Plan Administrator to use Jump Trading documents in a roughly $4 bill...
Two hugely popular fixed-income ETFs sit at the heart of many portfolios: TLT and LQD. This guide breaks down their d...
Lockheed Martin reports a record backlog near $194 billion, underscoring long-term demand for flagship programs and a...
The House advances a sweeping housing bill described as the first major housing since the 1990s, signaling a national...
Morgan Stanley's latest bottom up view argues that AI infrastructure demand will outpace supply, turning the Nebius s...
The United States is imposing 25% tariffs on imports from Brazil, with exemptions for key items like coffee and beef....
Netflix is tightening access to viewing data as it trims public reporting on audience insights, prompting a cautious ...
China’s Kimi K3 arrives in the crypto AI arena with benchmark wins that outpace Claude Fable and GPT 5.6 Sol. This ar...
A nuclear stock down 46% this year may look tempting, but ambition must be balanced with diligence. This guide breaks...
Vanguard, the $12 trillion firm, is edging into digital assets. This move could reshape access to crypto, fees, and r...
A new Zillow analysis finds more than 300,000 listed lots could significantly ease the U.S. housing shortage if devel...